» Articles » PMID: 27130306

Prevalence and Incidence of Alzheimer's Disease in Europe: A Meta-analysis

Overview
Journal Neurologia
Specialty Neurology
Date 2016 May 1
PMID 27130306
Citations 186
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A disease of unknown aetiology, Alzheimer's disease (AD) is the most common type of dementia. As the elderly population grows worldwide, the number of patients with AD also increases rapidly. The aim of this meta-analysis is to evaluate the prevalence and incidence of AD in Europe.

Methodology: We conducted a literature search on Medline, Scopus, and CINAHL Complete using the keywords «Alzheimer», «Alzheimer's disease», and «AD» combined with «prevalence», «incidence», and «epidemiology». A Bayesian random effects model with 95% credible intervals was used. The I statistic was applied to assess heterogeneity.

Results: The prevalence of Alzheimer's disease in Europe was estimated at 5.05% (95% CI, 4.73-5.39). The prevalence in men was 3.31% (95% CI, 2.85-3.80) and in women, 7.13% (95% CI, 6.56-7.72), and increased with age. The incidence of Alzheimer's disease in Europe was 11.08 per 1000 person-years (95% CI, 10.30-11.89). Broken down by sex, it was 7.02 per 1000 person-years (95% CI, 6.06-8.05) in men and 13.25 per 1000 person-years (95% CI, 12.05-14.51) in women; again these rates increased with age.

Conclusions: The results of our meta-analysis allow a better grasp of the impact of this disease in Europe.

Citing Articles

Deep brain stimulation of the nucleus basalis of Meynert in severe Alzheimer's disease.

Xu J, Liu B, Shang G, Liu S, Feng Z, Yang H J Alzheimers Dis Rep. 2025; 8(1):1573-1586.

PMID: 40034361 PMC: 11863734. DOI: 10.1177/25424823241296780.


Awareness of national dementia guidelines and management of oldest-old and frail people living with dementia: a European survey of geriatricians.

De Bondt E, Locquet P, Lopez M, Soysal P, Welsh T, Shenkin S Eur Geriatr Med. 2025; .

PMID: 39979530 DOI: 10.1007/s41999-025-01165-4.


Effects of aerobic exercise on cognitive function and quality of life in patients with Alzheimer's disease: a systematic review and meta-analysis.

Yang L, Yuan Z, Peng C BMJ Open. 2025; 15(1):e090623.

PMID: 39800395 PMC: 11752035. DOI: 10.1136/bmjopen-2024-090623.


Alzheimer's disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges.

Safiri S, Ghaffari Jolfayi A, Fazlollahi A, Morsali S, Sarkesh A, Daei Sorkhabi A Front Med (Lausanne). 2024; 11:1474043.

PMID: 39736972 PMC: 11682909. DOI: 10.3389/fmed.2024.1474043.


Exploring the Neuroprotective Effects of Grape Seed Procyanidins on Amyloid-β-Induced Toxicity in .

Gonzalez-Manzano S, Ayuda-Duran B, Martin-Sanz R, Garzon-Garcia L, Santos-Buelga C, Gonzalez-Paramas A Foods. 2024; 13(23).

PMID: 39682936 PMC: 11639893. DOI: 10.3390/foods13233865.